Literature DB >> 4700481

Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man.

L E Braverman, A Vagenakis, P Downs, A E Foster, K Sterling, S H Ingbar.   

Abstract

Studies of the effect of L-thyroxine administration (0.3 mg daily for 7-9 wk) on the peripheral metabolism of (131)I-labeled triiodothyronine (T(3)) and (125)I-labeled thyroxine (T(4)) and on the concentration and binding of T(4) and T(3) in serum were carried out in 11 euthyroid female subjects. Administration of L-thyroxine led to consistent increases in serum T(3) concentration (137 vs. 197 ng/100 ml), T(3) distribution space (39.3 vs. 51.7 liters), T(3) clearance rate (22.9 vs. 30.6 liters/day) and absolute T(3) disposal rate (30 vs. 58 mug/day), but no change in apparent fractional turnover rate (60.3 vs. 60.6%/day). The proportion and absolute concentration of free T(3) also increased during L-thyroxine administration. Increases in serum total T(4) concentration (7.3 vs. 12.8 mug/100 ml) and in both the proportion and absolute concentration of free thyroxine also occurred. In five of the subjects, the kinetics of peripheral T(4) turnover were simultaneously determined and a consistent increase in fractional turnover rate (9.7 vs. 14.2%/day), clearance rate (0.84 vs. 1.37 liters/day), and absolute disposal rate (64.2 vs. 185.0 mug/day) occurred during L-thyroxine administration. Despite these increases in the serum concentration and daily disposal rate of both T(4) and T(3), the patients were not clinically thyrotoxic. However, basal metabolic rate (BMR) values were marginally elevated and, as in frank thyrotoxicosis, T(4)-binding capacities of thyroxine-binding globulin (TBG) and thyroxine-binding prealbumin (TBPA) reduced, suggesting that subclinical thyrotoxicosis was present. Thus, the often recommended replacement dose of 0.3 mg L-thyroxine daily may be greater than that required to achieve the euthyroid state. The studies have also provided additional evidence of the peripheral conversion of T(4) to T(3) in man and have permitted the calculation that approximately one-third of exogenously administered T(4) underwent deiodination to form T(3). To the extent that a similar fractional conversion occurs in the normal state, it can be calculated that a major fraction of the T(3) in serum derives from the peripheral deiodination of T(4) and that only a lesser fraction derives from direct secretion by the thyroid gland.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4700481      PMCID: PMC302354          DOI: 10.1172/JCI107265

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Why does anybody use thyroid B.P.?

Authors:  A G MACGREGOR
Journal:  Lancet       Date:  1961-02-11       Impact factor: 79.321

2.  Oral Thyroxine in the Treatment of Myxoedema.

Authors:  F D Hart; N F Maclagan
Journal:  Br Med J       Date:  1950-03-04

3.  Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration.

Authors:  L E Braverman; A G Vagenakis; A E Foster; S H Ingbar
Journal:  J Clin Endocrinol Metab       Date:  1971-04       Impact factor: 5.958

4.  The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.

Authors:  K A Woeber; R J Sobel; S H Ingbar; K Sterling
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

5.  Thyroid hormone transport in the serum of patients with thyrotoxic Graves' disease before and after treatment.

Authors:  L E Braverman; A E Foster; S H Ingbar
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

6.  Triiodothyronine radioimmunoassay.

Authors:  J Lieblich; R D Utiger
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

7.  Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.

Authors:  J T Nicoloff; J C Low; J H Dussault; D A Fisher
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Thyroxine transport in thyrotoxicosis and hypothyroidism.

Authors:  M Inada; K Sterling
Journal:  J Clin Invest       Date:  1967-09       Impact factor: 14.808

9.  Therapeutic activity of desiccated thyroid substance, sodium L-thyroxine and D, L-triiodothyronine; a comparative study.

Authors:  T H MCGAVACK; H K RECKENDORF
Journal:  Am J Med       Date:  1956-05       Impact factor: 4.965

10.  Effects of norethandrolone on the transport and peripheral metabolism of thyroxine in patients lacking thyroxine-binding globulin. Observations on the physiological role of thyroxine-binding prealbumin.

Authors:  L E Braverman; T AvRuskin; M J Cullen; A G Vagenakis; S H Ingbar
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

View more
  23 in total

1.  Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man.

Authors:  M Inada; K Kasagi; S Kurata; Y Kazama; H Takayama; K Torizuka; M Fukase; T Soma
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  An assessment of daily production and significance of thyroidal secretion of 3, 3', 5'-triiodothyronine (reverse T3) in man.

Authors:  I J Chopra
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

4.  Serum thyroid hormones in patients on replacement or suppressive doses of L-thyroxine.

Authors:  S Rosenblatt; J M Hershman
Journal:  West J Med       Date:  1978-08

5.  Changes in the T4/T3 molar ratio following thyrotropin releasing hormone injection in cattle.

Authors:  A B Slebodziński; A L Wallace
Journal:  Experientia       Date:  1977-08-15

6.  Prophylaxis of recurrent goiter by high-dose L-thyroxine.

Authors:  P Goretzki; H D Roeher; G Horeyseck
Journal:  World J Surg       Date:  1981-11       Impact factor: 3.352

7.  What is the best test for monitoring levothyroxine therapy?

Authors:  M M Wong; R Volpé
Journal:  Can Med Assoc J       Date:  1981-05-01       Impact factor: 8.262

8.  Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.

Authors:  Islam R Younis; Mariam A Ahmed; Kenneth D Burman; Offie P Soldin; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2018-01-02       Impact factor: 6.568

9.  L-triiodothyronine and L-reverse-triiodothyronine generation in the human polymorphonuclear leukocyte.

Authors:  K A Woeber
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

10.  Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine.

Authors:  J C Ingbar; M Borges; S Iflah; R E Kleinmann; L E Braverman; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1982 Mar-Apr       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.